#vaccine research

Researchers halt the Mosaico study after an experimental vaccine was found to be safe but not effective against HIV.

A personalized cancer vaccine plus Keytuda lowered the risk of melanoma coming back after surgery.

A single vaccine dose delivered to nose aims to protect children and adults against COVID.

A vaccine using mRNA technology induced an immune response in mice and ferrets against 20 different types of influenza.

Experimental vaccine aims to train B cells to produce broadly neutralizing antibodies that target HIV.

Fauci, who has directed the National Institute of Allergy and Infectious Diseases since 1984, will step down in December.

EBV causes mononucleosis and certain cancers, and it may play a role in multiple sclerosis and long COVID.

Nearly all HIV-positive study participants achieved protective antibody levels after two doses of Heplisav-B.

An experimental vaccine produced an immune response to a range of different coronaviruses in mice and monkeys, including SARS-CoV-2.

The research is vital because Epstein-Barr virus is linked to cancers, lupus, rheumatoid arthritis, multiple sclerosis and other conditions.

Vaccines designed to produce a strong T cell response may help protect against current and future SARS-CoV-2 variants.

CoVac-1 induced T-cell responses in about 90% of immunocompromised people with impaired B-cell function.

The quick spread of the BA.2 subvariant is likely due to its greater infectiousness rather than its ability to evade the immune system.

NIAID is preparing for the possibility of future variants evading protection against currently available COVID-19 vaccines.

The benefits of achieving herd immunity thresholds have been less successful with respiratory viruses that continually mutate.

Researchers showed that B cells evolve after COVID-19 vaccination to help improve protection against SARS-CoV-2 over time.